MRC1 and carcinoma: The prevalence of carcinomas showing loss of MMR proteins across the intrinsic molecular subtypes ranged from 15% to 21% for dMMR (mean 16.8%) and 9% to 25% for hMMR (mean 15.1%), as shown in Figure 1 and Supplementary Tables 3 and 4 (available online).